Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes [Hematologic Malignancy]

Conclusion
Regardless of the presence of erythroid hyperplasia, calculating the percentage of BM blasts from NECs improves prognostic assessment of MDS. This fact should be considered in future WHO classification reviews.

Source: Journal of Clinical Oncology - September 12, 2016 Category: Cancer & Oncology Authors: Arenillas, Calvo, Luno, Senent, Alonso, Ramos, Ardanaz, Pedro, Tormo, Marco, Montoro, Diez-Campelo, Brunet, Arrizabalaga, Xicoy, Andreu, Bonanad, Jerez, Nomdedeu, Ferrer, Sanz, Florensa Tags: Epidemiology, Diagnosis & Staging Hematologic Malignancy Source Type: research